ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,132.09
1.34%
US Tech 100
17,434.40
2.10%
다우존스 지수
38,704.55
1.25%
Bitcoin
61,803.73
4.54%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Collegium Pharmaceutical Inc (COLL)

  7. Collegium Pharmaceutical Inc (COLL) 뉴스

COLL Collegium Pharmaceutical Inc

37.66
0.15 (0.40%)
최종 업데이트: 03:37:23
15분 지연
기업명 주식 심볼 시장 주식 타입
Collegium Pharmaceutical Inc COLL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.15 0.40% 37.66 03:37:23
개장가 저가 고가 종가 전일 종가
37.80 37.48 38.32 37.51
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/04/202421:00GLOBECollegium Announces Authorized Generic Agreement with Hikma..
25/04/202421:00GLOBECollegium to Report First Quarter 2024 Financial Results on..
11/04/202421:00GLOBECollegium Pharmaceutical, Inc. Announces Redemption of..
03/04/202421:00GLOBECollegium to Participate in 23rd Annual Needham Virtual..
05/03/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202407:24EDGAR2Form 144 - Report of proposed sale of securities
27/02/202406:39EDGAR2Form 144 - Report of proposed sale of securities
23/02/202406:09GLOBECollegium Reports Record Fourth Quarter and Full-Year 2023..
23/02/202406:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/02/202406:01EDGAR2Form 8-K - Current report
15/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202402:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202422:00GLOBECollegium to Report Fourth Quarter and Full-Year 2023..
19/01/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202406:20EDGAR2Form 144 - Report of proposed sale of securities
03/01/202422:03EDGAR2Form 8-K - Current report
03/01/202422:00GLOBECollegium Provides 2024 Financial Guidance
23/12/202306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202306:15EDGAR2Form 144 - Report of proposed sale of securities
21/12/202307:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:28EDGAR2Form 144 - Report of proposed sale of securities
20/12/202306:13EDGAR2Form 144 - Report of proposed sale of securities
19/12/202306:11EDGAR2Form 144 - Report of proposed sale of securities
30/11/202306:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202307:00EDGAR2Form 144 - Report of proposed sale of securities
27/11/202322:00GLOBEAppeals Court Upholds PTAB’s Finding of Invalidity of..
09/11/202322:05EDGAR2Form 8-K - Current report
09/11/202322:00GLOBECollegium Announces $25 Million Accelerated Share Repurchase..
08/11/202322:00GLOBECollegium to Participate in Upcoming Investor Conferences
08/11/202306:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:01EDGAR2Form 8-K - Current report
08/11/202306:01GLOBECollegium Reports Third Quarter 2023 Financial Results
24/10/202321:00GLOBECollegium to Report Third Quarter 2023 Financial Results on..
28/08/202321:00GLOBECollegium Announces 10 Poster Presentations at PAINWeek..
24/08/202321:05EDGAR2Form 8-K - Current report
24/08/202321:00GLOBECollegium Announces Extension of Nucynta Regulatory..
11/08/202305:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/08/202320:40EDGAR2Form 8-K - Current report
07/08/202320:30GLOBECollegium Announces $50 Million Accelerated Share Repurchase..
04/08/202305:03EDGAR2Form 8-K - Current report
04/08/202305:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202305:01GLOBECollegium Reports Record 1H’23 Net Revenue of $280.3..
20/07/202321:00GLOBECollegium to Report Second Quarter 2023 Financial Results on..
29/06/202305:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/06/202321:00GLOBECollegium to Participate in Jefferies Healthcare Conference
05/05/202305:01GLOBECollegium Reports First Quarter 2023 Financial Results

최근 히스토리

NASDAQ
COLL
Collegium Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유